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Abstract
Background: Previous studies have documented the feasibility of home-based cardiac rehabilitation programmes
in low-risk patients with ischemic heart disease, but a similar solution needs to be found for patients at moderate
cardiovascular risk. The objective of this study was to analyse the effectiveness and safety of a home-based cardiac
rehabilitation programme of mixed surveillance in patients with ischemic cardiopathology at moderate
cardiovascular risk.
Methods: A randomised, controlled clinical trial was designed wherein 28 patients with stable coronary artery disease
at moderate cardiovascular risk, who met the selection criteria for this study, participated. Of these, 14 were assigned to
the group undergoing traditional cardiac rehabilitation in hospital (control group) and 14 were assigned to the home-
based mixed surveillance programme (experimental group). The patients in the experimental group went to the cardiac
rehabilitation unit once a week and exercised at home, which was monitored with a remote electrocardiographic
monitoring device (NUUBO®). The in-home exercises comprised of walking at 70% of heart rate reserve during the first
month, and 80% during the second month, for 1 h per day at a frequency of 5 to 7 days per week. A two-way repeated
measures analysis of variance (ANOVA) was performed to evaluate the effects of time (before and after intervention)
and time-group interaction regarding exercise capacity, risk profile, cardiovascular complications, and quality of life.
Results: No significant differences were observed between the traditional cardiac rehabilitation group and the home-
based with mixed surveillance group for exercise time and METS achieved during the exertion test, and the recovery
rate in the first minute (which increased in both groups after the intervention). The only difference between the two
groups was for quality of life scores (10.93 [IC95%: 17.251, 3.334, p = 0.007] vs −4.314 [IC95%: −11.414, 2.787; p = 0.206]).
No serious heart-related complications were recorded during the cardiac rehabilitation programme.
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Conclusions: The home-based cardiac rehabilitation programme with mixed surveillance appears to be as effective and
safe as the traditional model in patients with ischemic heart disease who are at moderate cardiovascular risk. However,
the cardiac rehabilitation programmes carried out in hospital seems to have better results in improving the quality of life.
Trial registration: Retrospectively registered NCT02796404 (May 23, 2016).
Keywords: Telemedicine, Rehabilitation, Exercise therapy, Myocardial ischemia
Background
Cardiovascular diseases are the main causes of mortality
in today’s society and the primary cause of hospital admis-
sions. They are responsible for up to 30% of all deaths
worldwide and 48% of deaths in Europe, and it is expected
that these figures will increase in the coming years [1].
Cardiac rehabilitation is not a new concept. Various
studies have shown the effectiveness of these pro-
grammes in reducing cardiac mortality [2–4] by between
27 and 31% in patients with coronary heart disease; un-
fortunately, participation levels in these programmes
continue to be low in some countries [1]. Sociodemo-
graphic factors, factors related to programme availability
and accessibility, and the low referral rates of patients to
this service are associated with lower rates of patient
participation in cardiac rehabilitation programmes [5, 6].
All of these challenges have led to the recent develop-
ment of alternative models of cardiac rehabilitation, with
innovative approaches to improve the delivery and use
of these programmes and to provide solutions to these
barriers [7].
The effectiveness of home-base cardiac rehabilitation/
secondary prevention programs is not new [8]. Studies
carried out in the 1980’s documented the feasibility of
home-based cardiac rehabilitation programmes in low-
risk patients with ischaemic cardiomyopathy [9]. While
some authors maintained that such programmes provided
a solution to the low patient participation in rehabilitation
programmes [9], a solution also needs to be found for
moderate-risk patients so that they can follow a safe and
effective home-based cardiac rehabilitation programme.
Implementing telemedicine in cardiac rehabilitation
through the use of technology could partially reduce the
logistical problems described above. Telemonitoring de-
vices can allow the patient to be monitored at home so
that the patient does not have to travel, and they can
improve the efficiency of health care processes by in-
corporating this information in a comprehensive man-
agement programme for cardiac patients [10, 11].
As with any other form of health technology, the ef-
fectiveness and safety of these devices must be assessed
before their use is extended [10]. In this sense, some al-
ternative home-based cardiac rehabilitation/secondary
prevention program with remote monitoring has been
previously described [12], but clinical trials evaluating
the efficacy of these programs in patients with high risk,
greater comorbidity, and also with stable angina are ne-
cessary [8].
If home-based cardiac rehabilitation programmes with
telemonitoring offer the same safety and effectiveness in
moderate-risk patients, it could herald a change in
health insurance policies to extend the coverage of these
programmes. This would allow a greater number of pa-
tients to access cardiac rehabilitation programmes with-
out increasing the total costs [6].
Very few studies have evaluated a home-based cardiac
rehabilitation programme model with mixed surveil-
lance, and the studies to date have focused on patients
with a low-risk profile. For this reason, it was necessary
to develop an alternative home-based cardiac rehabilita-
tion model aimed at higher-risk patients.
The objective of this study was to analyse the effective-
ness and safety of a home-based cardiac rehabilitation
programme with mixed surveillance in moderate-risk
patients with ischaemic cardiomyopathy.
Methods
Study population
Patients with stable ischaemic cardiomyopathy who had
undergone revascularisation by either stent-angioplasty
or by-pass surgery, who were at moderate risk according
to the Spanish Cardiology Society’s clinical practice
guidelines (Table 1) [8, 13–17], aged ≤ 75, with a good
cognitive level, a capacity to perform aerobic exercise on
a treadmill or stationary bike, and knowledge of how to
use a smartphone or tablet were included in this study.
Patients also had to meet at least one of the following
inclusion criteria: ventricular dysfunction using ejection
fraction (EF) 40–55%, functional capacity 5–7 METS,
and/or raised blood pressure with exertion.
We excluded patients with malignant arrhythmias (ven-
tricular fibrillation >24 h after the acute myocardial infarc-
tion, ventricular tachycardia, grade 2 or 3 AV block, atrial
fibrillation in patients with Wolff-Parkinson-White
syndrome, fibrillation or paroxysmal flutter with rapid
ventricular response and haemodynamic deterioration,
ventricular extrasystole which increases during exertion
and uncontrolled supraventricular tachycardia), previous
infarctions, ischemia induced by exercise, unstable angina,
disease not amenable to revascularisation, poorly-controlled
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high blood pressure, associated valvular heart disease,
pacemaker or ICD-CRT and locomotor system, or a
neurological or respiratory pathology that would make
walking for prolonged periods difficult.
The study protocol complied with the Declaration of
Helsinki and was reviewed and approved by the Comité
de Ética Interprovincial de Málaga [Malaga Interprovincial
Ethics Committee] belonging to the Consejería de Salud
[Health Council] of the Junta de Andalucía [Regional Gov-
ernment of Andalusia] and registered in the clinical trials
register (NCT02796404). The study met the requirements
of the Andalusian Health System order SAS 3470/2009
and with Organic Law 15/1999 of 13 December for the
Protection of Data of a personal nature.
The participants received information about the study
methods and gave their written informed consent.
Study design
This is an ongoing randomised controlled multicentre
clinical trial (NCT02796404). In this paper, we present
preliminary data from one of the participating centres,
the Hospital Virgen de la Victoria in Malaga (Spain).
The patients were assigned randomly by an independ-
ent investigator to either the control group, which par-
ticipated in the usual cardiac rehabilitation programme
at the hospital, or to the experimental group, which
participated in the home-based mixed surveillance
programme. The software program Epidat was used for
the randomization, ensuring a balanced distribution in
both groups. The algorithm generated by this program
established that every time a new subject was assigned
to a particular group, the probability that that subject
was assigned to that group would be inversely propor-
tional to the number of individuals included in it up to
that point.
The cardiac rehabilitation programme in both cases
had a duration of 2 months. There was only one patient
who withdrew from the home-based mixed surveillance
group due to personal reasons. The outline design is
shown in Fig. 1.
Intervention
The two cardiac rehabilitation programs were started 4–6
months after the patients were discharged from the hos-
pital. Both programs included physical exercise, health
education, and physiotherapy, with a duration of 2 months
in both cases.
The usual cardiac rehabilitation programme took place
in the cardiac rehabilitation unit of the Hospital Virgen
de la Victoria in Malaga (Spain). The patients in this
group attended the hospital exercise programme 3 times
a week (24 sessions) and were encouraged to do exercise
at home according to the European Society of Cardi-
ology guidelines [18].
The patients in the home-based cardiac rehabilita-
tion with mixed surveillance group only went to the
cardiac rehabilitation unit once a week. During this
visit, they had a supervised physical exercise session
that was identical to the usual cardiac rehabilitation
session. Then they exercised at home following a
walking program for 1 h in duration at 70% of the re-
serve heart rate following the Karvonen formula dur-
ing the first month and 80% during the second,
which was monitored with a remote electrocardio-
graphic monitoring device NUUBO®, for at least two
more days a week, although they were encouraged to
exercise every day.
The NUUBO® system uses Bluetooth wireless tech-
nology and biometric vests using textile electrodes de-
veloped and patented by Nuubo, BlendFix Sensor
Electrode Technology, which makes its use simple.
On the first day, the patients were instructed on how
to use this device’s mobile application and they were
all given a smartphone with Internet connection and
the NUUBO® application pre-installed. Each patient
Table 1 Classification criteria
Risk Clinical Variables Complementary Tests Physical
Capacity
Low Age <50 years




No signs of ischemia.
Ejection fraction >50%.
Normal BP response to exercise.
No arrhythmias.
≥7 METS
Moderate Age >50 years
Killip I or II
No previous infarct.
Mild symptomology.
Effort angina or mild signs of ischemia.
Ejection fraction between 35-49%.
Mild BP elevation with effort.
Low grade arrhythmias.
Reversible thallium defect with effort.
>5 METS
High Killip II or III
Previous infarct.
Symptoms with low load.
Severe ischemia. ST depression of >2 mm
at a rate of less than 135 beats per minute.
Hypertensive response to effort.
Malignant arrhythmias.
<5 METS
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was registered on the server; clinical details were en-
tered along with the previously calculated and ad-
justed exercise heart rate and exercise time (60 min).
The exercise program prescribed for both groups
consisted of 15 min of warm-up exercise (stretching
and isotonic exercises), followed by 30 min of con-
tinuous aerobic exercise, alternating between treadmill
training 1 day and stationary bike training the next
day, at 70% of the reserve heart rate, following the
Karvonen formula during the first month and 80%
during the second. The intensity of the exercise was
calculated using the heart rate value obtained during
the stress test. The patients ended the exercise ses-
sion with a 15-min cool-down period. Once a week
the patients also did a prescribed strength-training
session consisting of one or two series of 10 repeti-
tions of exercise for the brachial biceps, brachial tri-
ceps, pectoris major, deltoids, and quadriceps at 20
MR (maximum resistance) that is equivalent to 50%
of 1MR, with a recovery time of 2–3 min recovery
time between each set of repetitions.
Both groups had a health education session at the hos-
pital once a week to improve awareness and understand-
ing about subjects related to the anatomy and function
of the heart, cardiovascular risk factors, physical exer-
cise, medication, diet, erectile dysfunction, and return-
ing to work.
All of the patients also attended a group psycho-
therapy support and assessment session once a week
to reduce the emotional impact of the disease, im-
prove their state of health, reduce their chances of
another infarction, help them accept their diagnosis,
and improve their quality of life.
Measurements
The following measurements were taken at the start of
the study and at the end of the 2-months cardiac re-
habilitation programmes.
Anthropometric measurements
The body weight of the patients was recorded using a
calibrated scale. The measurements were taken with pa-
tients wearing light clothes and no shoes. The body mass
index (BMI) was calculated based on the formula weight
(kg)/height2 (m). The abdominal circumference was
measured with a metric tape with the patient standing
up with legs together, arms by the side, and abdomen re-
laxed after a deep breath. The circumference of the area
located at mid-point between the costal edge and the
upper edge of the iliac crest was then measured.
Blood pressure
Systolic and diastolic blood pressure readings were taken
with an Omro M5-I ® electric sphygmomanometer. The
measurements were taken after 10 min of rest with the
arm on a table, and the average of three readings was
recorded.
Exercise capacity
The participants took an exertion test before enrolling in
the study to ensure that they could tolerate the exercise
and to determine their METS and exercise time (mi-
nutes). The exertion test was done on a treadmill (Gen-
eral Electrics®, Marquette - CASE 8000 Exercise Testing
System), following the clinical practice guidelines with
continual monitoring with 12-derivation electrocardio-
gram, using the Bruce protocol. The test ended when
Fig. 1 Flowchart of the study design
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the participants were exhausted or showed signs and/or
symptoms of intolerance.
Maximum heart rate reached in the stress test was re-
corded. The heart rate recovery rate during the first mi-
nute and the perceived exertion level according to the
Borg scale, RPE 6–20, were also recorded.
Laboratory parameters
The participant’s total cholesterol, HDL cholesterol, LDL
cholesterol, triglycerides, blood glucose and glycated
haemoglobin (HbA1c) were analysed in the Clinical
Analysis Laboratory of the Laboratory and Haematology
Clinical Management Unit of the Hospital Virgen de la
Victoria. The glucose, cholesterol and triglycerides levels
were recorded using the “Dimension Vista” measuring
equipment from Siemens of Grunelwald, Germany. The
HbA1c levels were determined using the Adams A1c,
HA-8180 V analyser. The glucose levels were measured
using the glucose hexokinase method. The total choles-
terol levels were analysed using the cholesterol oxidase
method, the HDL cholesterol levels were analysed with
the enzymatic magnesium dextransulphate method, and
the LDL cholesterol levels were analysed using the select-
ive detergent method. Finally, the triglycerides levels were
determined using the lipase/glycerol kinase method.
Assessment of health-related quality of life
The Medical Outcome Survey Short Form (SF-36) ques-
tionnaire was used to measure the quality of life. The
SF-36 consists of 36 items which assess 8 different di-
mensions, and the possible scores range from 0–100; the
variables assessed include limitations due to physical
problems, body pain, social function or role, mental
health, limitation due to emotional problems, vitality,
energy or fatigue, and general perception of health.
Studies published on the metric characteristics of the
Spanish version of the SF-36 have provided enough
evidence in support of its reliability, validity, and sen-
sitivity [19].
Cardiovascular complications
Complications that arose during the hospital and home-
based cardiac rehabilitation programmes were recorded,
and they included AMI, severe arrhythmias, cardiorespi-
ratory arrest or death, arterial hypotension, arterial
hypertension, hypoglycaemia, hyperglycaemia, or inter-
mittent claudication due to peripheral arterial disease.
Statistical analysis
A two-way repeated measures analysis of variance
(ANOVA) was carried out to evaluate the effect of the
time (before and after intervention) and the effect of
time-group interaction. The normality of distributions
was verified using the Shapiro-Wilk test. Descriptive
analyses were performed to characterise the sample and
the study outcomes using the central tendency, confi-
dence interval, and percentage measures. The level of
significance was set at p < 0.05 for all tests.
Results
A total of 28 patients initially participated in the study,
all men with an average age of 56.07 (±8.92); 14 of the
participants were assigned to the usual cardiac rehabili-
tation group (control group) and 14 were assigned to the
home-based mixed surveillance programme (experimen-
tal group). During the intervention phase, one patient
from the experimental group withdrew from the study
for personal reasons. The initial characteristics of the
sample are shown in Table 2. No significant differences
were seen between both groups except for the number
of patients presenting with diabetes mellitus and the
maximum heart rate achieved in the stress test. The dif-
ferences in this latter parameter probably can be related
to the response to the medication of some patients since
there are no differences in METS achieved nor in the
time of exercise.
The right coronary and anterior descending arteries
were the most affected among patients with either
single-vessel disease or double-vessel lesions in both
groups; while in patients with triple-vessel disease the af-
fected arteries were either the anterior descending, cir-
cumflex, and marginal obtuse arteries, or the anterior
descending, right coronary, and circumflex arteries. In
general, the majority of patients underwent PCI, and
78.6% of the patients received pharmacoactive stents.
The medication prescribed to patients is similar in
both groups (Table 3). Therapeutic doses were adjusted
in each case to maintain heart rate, blood pressure and
blood glucose levels within the recommended levels
according to clinical practice guidelines for the con-
trol of cardiovascular risk factors in patients with
heart disease Ischemic.
The exercise time and METS achieved during the ex-
ertion test as well as the recovery rate in the first minute
increased in both groups after the intervention, with no
significant differences being found between the usual
cardiac rehabilitation group and the home-based with
mixed surveillance group (Table 4).
The maximum heart rate reached during the stress
test, however, appeared to be significantly differences be-
tween both groups, although it is not possible to affirm
that the heart rate in any individual significantly changed
(usual cardiac rehabilitation group: −17.57 [IC95%:
−35.348, .205, p = 0.052]; home-based with mixed sur-
veillance group 9.46 [IC95%: −.133, 19.056, p = 0.053]).
The only differences found between the two groups
were in quality of life. The results obtained in the SF-36
post-intervention were significantly higher in the usual
Bravo-Escobar et al. BMC Cardiovascular Disorders  (2017) 17:66 Page 5 of 11
Table 2 Baseline characteristics of the study population
Hospital (n = 14) Home (n = 13) p-value
Age (years) 55.64 (11.35) 56.50 (6.01) ns
Sex Male n (%) 14 (100) 14 (100) ns
Risk factors
Hypertension n (%) 11 (78.57) 9 (64.28) ns
Hyperlipidaemia n (%) 5 (35.71) 7 (50) ns
Diabetes n (%) 1 (7.14) 6 (42.85) 0.029*
Overweight n (%) 8 (57.14) 5 (35.71) ns
Obese n (%) 6 (42.85) 6 (42.85) ns
BMI (kg/m2) 29.29 (3.62) 28.64 (3.65) ns
Waist-hip ratio (cm) 106.42 (8.84) 104.14 (10.21) ns
Current smokers n (%) 2 (14.28) 2 (14.28) ns
Coronary artery disease
Monovessel n (%) 3 (21.42) 8 (57.14) ns
Double vessel n (%) 5 (35.71) 4 (28.57) ns
Triple vessel n (%) 5 (35.71) 1 (7.14) ns
Revascularization technique
CABG n (%) 2 (14.3) 1 (7.1) ns
PCI n (%) 11 (78.6) 11 (78.6) ns
PCI & CABG n (%) 1 (7.1) 2 (14.3) ns
Blood pressure
Systolic blood pressure (mmHg) 115.35 (23.73) 119.35 (24.05) ns
Diastolic blood pressure (mmHg) 69.28 (11.41) 71.50 (9.48) ns
Exercise stress test
Exercise time (min) 5.47 (2.08) 5.84 (2.66) ns
METS 7.10 (1.97) 7.55 (2.77) ns
Heart rate maximal (bpm) 132.84 (16.11) 106.21 (32.58) 0.02*
% of predicted peak HR. 79.86 (12.27) 65.10 (20.09) 0.02*
Hypertension response n (%) 5 (41.7) 4 (28.6) ns
Clinical positive response n (%) 1 (7.1) 0 (0) ns
Electrical positive response n (%) 2 (14.3) 0 (0) ns
Ejection Fraction (EF) 52.33 (3.51) 51.00 (7.9) ns
Laboratory values
Total cholesterol (mg/dL) 130.50 (32.16) 145.71 (29.35) ns
HDL cholesterol (mg/dL) 37.85 (8.07) 39.84 (9.21) ns
LDL cholesterol (mg/dL) 67.17 (23.19) 73.68 (25.62) ns
Triglycerides (mg/dL) 161.21 (72.31) 148.35 (58.16) ns
Glucose (mg/dL) 94.92 (13.56) 111.00 (28.03) ns
HbA1c 5.62 (1.05) 5.72 (0.93) ns
Health-related quality of life
SF-36 (score) 53.33 (19.80) 48.44 (20.89) ns
Values are presented as mean (SD) unless stated otherwise
* Significance level p < 0.05
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cardiac rehabilitation group (10.93 [IC95%: 17.251,
3.334, p = 0.007]) with no changes compared to the ini-
tial status in the home-based with mixed surveillance
group (−4.314 [IC95%: −11.414, 2.787; p = 0.206]).
During the training sessions, two patients from the
control group presented with angina-type pain without
electrical changes evident on telemonitoring which sub-
sided with rest, one patient presented an arrhythmia (de
novo atrial fibrillation), two patients had a hypertensive
response to the exercise which subsided with rest, and
one patient had a hypotensive response which required
the administration of intravenous saline solution.
In the experimental group, one patient had a hyperten-
sive response to exercise which subsided during the
cool-down phase, and one patient had a hypotensive re-
sponse which required the intravenous administration of
saline solution; both events occurred during the super-
vised training sessions carried out at the hospital.
No patient required treatment at the hospital’s Acci-
dent & Emergency (A&E) department.
The control group had 24 supervised training sessions
in the hospital. Although it was recommended that the
control group also exercise at home, we do not have a
record of -home sessions. The experimental group’s
patients completed an average of 36 sessions at home.
The home-based training sessions lasted over an hour in
83.3% of cases. During the home-based exercise sessions
supervised using the NUUBO® device, 8 patients pressed
the alarm button in 20 training sessions, of which 3 pa-
tients reported angina-type pain during the exercise
which subsided with rest; no ECG changes were seen on
the recording in any of the cases. None of the other pa-
tients presented with angina-type pain or ECG changes
during the home-based training sessions.
No serious cardiovascular complications were recorded
during the cardiac rehabilitation programme.
Discussion
The majority of patients who participate in cardiac re-
habilitation programmes are middle-aged men. A num-
ber of studies have identified the patients who could
benefit the most from cardiac rehabilitation and they in-
clude patients with significant functional deterioration,
patients of advanced age, women, and ethnic groups, al-
though these patients are the least likely to participate in
cardiac rehabilitation programmes [1, 5]. Several studies
have concluded that the effectiveness and safety of these
home-based programmes could reduce inequality by im-
proving access to this type of health service [20–23].
This study demonstrated that the cardiac rehabilitation
with a mixed surveillance programme was as effective as
the usual programme for improving functional capacity
in moderate-risk patients.
Other studies have obtained similar results in low-risk
patients after coronary revascularisation surgery and in
patients of advanced age [8, 22, 24, 25]. While some of
these studies analysed exercise capacity based on other
parameters such as oxygen consumption, the shuttle
walk test, or total cycle work capacity, the studies all
found that home-based exercise programmes improved
exercise capacity, and they found no differences when
they compared them to hospital programmes [25].
When the training protocols for the different interven-
tion models were compared, considerable variation was
seen in the duration, frequency, and intensity of the ex-
ercise [25]. Despite these variations, all of the studies
showed a beneficial short-term impact on exercise cap-
acity after low-risk or moderate-risk patients completed
a home-based cardiac rehabilitation programme. Fur-
thermore, some of the studies demonstrated that long-
term home-based programmes had better results than
programmes carried out in hospitals.
The improved exercise time and recovery rate detected
in the first minute also suggest an improved survival
prognosis in patients with coronary heart disease [26].
All of these factors, together with the intensity of the ex-
ercise attained over the final weeks, could explain the in-
creased subjective perception of the exertion measured
Table 3 Prescribed medication to patients
Medication Hospital (n = 14) Home (n = 13)
Antiplatelet agents - -
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using the Borg scale in both groups, and the improved
risk profile of these patients.
With respect to the maximum heart rate achieved in
the stress test, although the sample is not large enough
to affirm that the changes observed in each separate
group are statistically significant, it is sufficient to affirm
the different effects of exercise on both groups. The de-
crease in heart rate in the stress test of the control group
together with the increase in exercise time and the
METs that were achieved, translate into a better
adaptation to exercise than that of the experimental
group. This is probably due to the fact that it was
not possible to control caloric consumption per train-
ing session, the amount of time they remained at goal
intensity during the -home exercise session, and walk-
ing speed, which are aspects that are related to
improvement in prognosis and reduction in mortality
[3, 4] and hospitalizations of these patients [2]. In this
sense, the results obtained from this pilot study allow
for the introduction of improvements in the design of
these devices, which allow not only the monitoring of
these patients, offering an efficient and safe way to
exercise, but they also provide the patient enough
flexibility to exercise anywhere with a workload that
is adequate and easily modifiable [12].
The beneficial effect of exercise on lipids and the me-
tabolism of carbohydrates has been documented in sev-
eral studies, but in this study we found no significant
differences when we compared the readings in both
groups. The patients who participated in the study from
the start presented with blood glucose, cholesterol and
triglycerides readings within the normal ranges; only the
HDL levels were below optimal levels. Other authors
have also not seen improvements in HDL levels in pa-
tients with coronary heart disease [27]. In general, there
is a high variability in results when the effect of exercise
on the metabolism of lipids are analysed due to the het-
erogeneity of the study methods, duration of studies,
populations, exercise protocols, and other contributory
factors such as diet or lipid-lowering pharmacological
agents. It is also known that in adults aged 50 and over,
prolonged periods of exercise are needed to achieve a
change in lipid metabolism, so the intervention duration
of two months may not have been long enough to
achieve an effect comparable to the results seen in other
studies [28–30] on the lipid profile, body mass index,
and abdominal circumference.
In terms of the quality of life, other studies have shown
a significant improvement in both groups [30–34], and
sometimes the effect was even greater in the home-based
Table 4 Measures results obtained before and after the two different cardiac rehabilitation programs
Hospital based cardiac rehabilitation program Home based cardiac rehabilitation program p-
valuea
p-
valuebBefore After Before After
METS 7.10 (1.97) 8.45 (1.71) 7.55 (2.77) 8.28 (2.62) 0.03* 0.49
Exercise time (min) 5.47 (2.08) 6.87 (1.67) 5.84 (2.66) 6.38 (1.80) 0.03* 0.32
Heart rate maximal (bpm) 132.84 (16.11) 123.38 (17.38) 107.23 (32.58) 123.84 (22.61) - 0.009**
% of predicted peak HR. 79.86 (12.27) 75.16 (9.2) 65.10 (20.09) 75.81 (14.07) . 0.008**
Borg Scale 12.57 (1.15) 13.57 (1.22) 13.07 (1.49) 13.69 (1.18) 0.015* 0.54
Recovery rate 1 min (bpm) 13.85 (5.02) 17.21 (6.29) 11.63 (7.41) 13.81 (4.46) 0.008** 0.54
BMI (kg/m2) 29.29 (3.62) 29.08 (37.6) 28.60 (3.80) 29.08 (4.33) 0.54 0.13
Waist-hip ratio (cm) 106.42 (8.84) 105.35 (9.96) 103.84 (10.56) 103.69 (10.59) 0.24 0.37
Total cholesterol (mg/dL) 130.50 (32.16) 138.21 (25.41) 142.66 (29.44) 135.91 (23.43) 0.91 0.10
HDL cholesterol (mg/dL) 37.85 (8.07) 20.57 (8.75) 39.45 (8.99) 40.45 (7.01) 0.24 0.58
LDL cholesterol (mg/dL) 62.17 (23.19) 68.62 (16.63) 70.30 (26.14) 61.13 (15.50) 0.74 0.06
Triglycerides (mg/dL) 161.21 (72.31) 161.07 (102.20) 149.83 (61.56) 160.08 (84.71) 0.77 0.76
Glucose (mg/dL) 94.92 (13.56) 104.07 (27.73) 109.83 (28.67) 106.75 (14.61) 0.57 0.26
HbA1c 5.62 (1.05) 5.75 (1.30) 6.05 (1.18) 6.15 (1.36) 0.35 0.90
Systolic blood pressure (mm Hg) 115.76 (24.65) 119.23 (19.45) 119.35 (24.05) 120.35 (16.69) 0.65 0.80
Diastolic blood pressure (mm Hg) 69.23 (11.87) 72.30 (11.65) 71.50 (9.48) 72.14 (11.21) 0.45 0.62
SF-36 (score) 53.33 (19.80) 63.63 (21.00) 47.93 (22.57) 43.62 (24.20) - 0.004**
Data are presented as mean values (SD)
aSignificance level for the hypothesis of no time effect
bSignificance level for the hypothesis of no time x group effect (difference in outcome improvement between the two programs)
*Significance level p < 0.05
**Significance level p < 0.01
Significant values are highlighted in bold
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group [30]. However, in this study we detected an im-
provement in the usual cardiac rehabilitation group. The
differences in the risk profile of the patients as well as
other associated psychosocial factors may partially explain
the results we obtained [35].
The exercise sessions at the hospital likely promoted
social support due to the nature of the programmes and
this could have impacted on patients’ perceived quality
of life, as they feel like they were part of a group, with
everything that entails [36]. It is be plausible that the ex-
ercise group in the traditional cardiac rehabilitation
model achieved greater social cohesion and thus the
programme had a greater impact on their quality of life.
The strategies which increased the frequency of exer-
cise could in turn have contributed to a faster improve-
ment in the perceived quality of life [30].
These and other factors, such as creating a home-based
support network, will need to be taken into consideration
when designing home-based cardiac rehabilitation pro-
grammes in order to achieve better results when it comes
to the quality of life.
The safety of the exercise programme for moderate-
risk patients was an important question, particularly
when the programme was performed at home [37]. The
safety of the exercise programme for patients with cor-
onary heart disease has generally been related to the in-
tensity and duration of the training and the patient
selection. The individual risk assessment is a fundamen-
tal starting point here which serves as a guide for
decision-making, among other things, when it comes to
determining the right level of surveillance [11].
There are a wide variety of monitoring and surveil-
lance strategies for home [9, 38, 39], but there are very
few studies which use ECG monitoring systems through
various devices [1, 12, 21, 22, 39–41]. Ades et al. [9]
maintained that not all patients require transtelephonic
monitoring in all sessions. Indeed, they suggested the se-
lective use of this technology only in the initial sessions,
and/or depending on the characteristics of each patient
and their individual progress, probably because they did
not differentiate between low and moderate-risk patients
in their sample. However, Giallura et al. [21] maintained
that telemonitoring improved compliance and the results
of a home-based cardiac rehabilitation programme, par-
ticularly the functional capacity profile, compared with
patients who participated in a home-based cardiac re-
habilitation programme without ECG monitoring.
Bearing in mind the characteristics of the patients in
this study, the mixed surveillance model described re-
quired, for the whole programme, the use of a telemetric
monitoring system which allowed the information stored
on the device during the exercise session to be sent from
home so that it could be evaluated at the hospital with-
out the patient needing to go to the centre. We have not
found any other study which assessed a similar mixed
surveillance model for the whole programme in
moderate-risk patients.
Patients generally accepted this new exercise monitor-
ing model away from the hospital, which made the tele-
monitoring system mixed surveillance exercise
programme a viable option for moderate-risk patients.
However, this intervention model in higher-risk pa-
tients establishes a new scenario in which it is not only
necessary to have a clear definition of the risks and re-
sponsibilities, but also the various clinical skills among
the health professionals [10].
Other studies have demonstrated the safety of home-
based cardiac rehabilitation programmes in lower-risk
patients [23, 38, 39]. Bearing in mind that the com-
plications recorded in the home-based group with
mixed surveillance were minor, we believe that this
model of intervention was safe in low-risk patients
with coronary heart disease.
There are some limitations derived from the sample
size. Although the sample size in the current study are
small, this is a preliminary investigation regarding an al-
ternative method for mixed-home supervision, which
that could improve access to this type of program for
cardiac patients with a risk-profile that is greater than
has been previously reported. The study currently con-
tinues to recruit patients. Further, another limitation of
the current study is that the sample only consists of men
since none of the women who came in for an evaluation
for the cardiac rehabilitation program met the inclusion
criteria for taking part in this study. Additionally, with
relation to heart disease, despite the randomization pro-
cedure described in the manuscript, the experimental
group consisted of a majority of patients presenting with
monovessel disease, while the majority of the control
group had presented with two or three vessel disease.
However, all the patients had stable ischemic heart dis-
ease and met the moderate risk criteria. Finally, although
it was recommended that the control group exercise at
home, we do not have a record of in-home sessions.
In spite of these limitations, the results of this study
may help with the design of home-based programs that
are adapted to different sociodemographic situations for
moderate-risk coronary patients and also in the design of
new technologies that are adapted to the profiles of these
patients, which can improve access to Cardiac Rehabilita-
tion services. However, the long-term effects need to be
assessed for this patient population through multicentre
studies to determine the effectiveness and acceptability of
these mixed surveillance programmes based on telemedi-
cine in different contexts. It is necessary to point out that
the study is continuing with the added participation of dif-
ferent hospitals (multicentre study) and we will soon have
the first results on long-term monitoring.
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Conclusion
A home-based cardiac rehabilitation programme with
mixed surveillance was as effective and safe as the usual
model in moderate-risk patients with ischaemic cardio-
myopathy. However, the cardiac rehabilitation pro-
grammes carried out at the hospital had a greater
impact on the patients’ quality of life. The results pre-
sented here suggest that the implementation of this
programme would represent an improvement in the care
quality of the public health services as it could offer ben-
efits in the type and number of potential patients helped,
the possibility of personalised treatment tailored to the
different lifestyles or needs of patients, and thus enhance
treatment adherence. Future lines of research should
analyse how the design of home-based programmes
could improve these results, bearing in mind the multi-
dimensional nature of quality of life.
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